What is required for achieving HCV elimination in Singapore? A modeling study

Clicks: 251
ID: 111346
2020
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #12 of 19 articles by views in Journal of gastroenterology and hepatology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
HCV elimination is achievable in Singapore, but even with declining IDU requires immediate treatment scale-up among PWID. Harm reduction provision reduces treatments required and provides additional benefits.
Reference Key
a2020journalwhat Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Chaillon A;Thurairajah PH;Hsiang JC;Martin NK;;
Journal Journal of gastroenterology and hepatology
Year 2020
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/32777859
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE pubmed abstract nih national institutes of health national library of medicine pmid:32777859 doi:10.1111/jgh.15211 antoine chaillon prem harichander thurairajah natasha k martin

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.